"I was raised by hippie-dippy parents in Oregon. No vaccines, was born at home, homeschooled for 16 years, etc. I have since ...

Merck projects $200 million in tariff costs, boosts U.S. manufacturing plans, and continues M&A efforts amid external pressures and shifting market dynamics.

Two of Gilead Sciences' most important drugs missed sales expectations late Thursday. Gilead stock fell early Friday.

Africa has taken a bold step to improve access to safe and effective medicines by approving and listing five human medicinal ...